- Report
- September 2025
Latin America
From €8572EUR$9,500USD£7,408GBP
- Report
- September 2025
Japan, United States, ... Japan, United States, Europe, Global
From €13084EUR$14,500USD£11,307GBP
- Report
- September 2025
Europe, Global
From €8572EUR$9,500USD£7,408GBP
- Report
- September 2025
- 28 Pages
Switzerland
From €995EUR$1,181USD£890GBP
- Report
- September 2025
- 23 Pages
Estonia
From €995EUR$1,181USD£890GBP
From €995EUR$1,181USD£890GBP
- Report
- September 2025
- 24 Pages
Ecuador
From €995EUR$1,181USD£890GBP
- Report
- September 2025
- 23 Pages
Georgia
From €995EUR$1,181USD£890GBP
- Report
- September 2025
- 25 Pages
Switzerland
From €995EUR$1,181USD£890GBP
From €995EUR$1,181USD£890GBP
- Report
- September 2025
- 23 Pages
Ecuador
From €995EUR$1,181USD£890GBP
- Report
- September 2025
- 28 Pages
Switzerland
From €995EUR$1,181USD£890GBP
- Report
- September 2025
- 22 Pages
Estonia
From €995EUR$1,181USD£890GBP
- Report
- September 2025
- 22 Pages
Georgia
From €995EUR$1,181USD£890GBP
- Report
- September 2025
- 31 Pages
United States
From €995EUR$1,181USD£890GBP
From €995EUR$1,181USD£890GBP
- Report
- September 2025
- 29 Pages
Japan
From €995EUR$1,181USD£890GBP
- Report
- September 2025
- 27 Pages
Belgium
From €995EUR$1,181USD£890GBP
- Report
- September 2025
- 22 Pages
Bulgaria
From €995EUR$1,181USD£890GBP
- Report
- September 2025
- 25 Pages
Czech Republic
From €995EUR$1,181USD£890GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more